
### [NCIT:C4904](http://purl.obolibrary.org/obo/NCIT_C4904)
**Label:** Metastatic Malignant Neoplasm in the Lymph Nodes

**Subclasses:** 

**Class expressions from DL-Learner:**

- [UBERON:0000029](http://purl.obolibrary.org/obo/UBERON_0000029) (lymph node) 62.50%
- [NCIT:C41444](http://purl.obolibrary.org/obo/NCIT_C41444) (Secondary Lesion) 62.50%
- [NCIT:C40557](http://purl.obolibrary.org/obo/NCIT_C40557) (Metastatic Lesion) 62.50%
- Thing 51.60%
- [UBERON:0005057](http://purl.obolibrary.org/obo/UBERON_0005057) (immune organ) 37.50%
- [NCIT:C3824](http://purl.obolibrary.org/obo/NCIT_C3824) (Lesion) 33.91%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 27.53%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 27.15%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 15.74%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 14.98%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 14.87%
- [UBERON:0000061](http://purl.obolibrary.org/obo/UBERON_0000061) (anatomical structure) 14.17%
- [UBERON:0000465](http://purl.obolibrary.org/obo/UBERON_0000465) (material anatomical entity) 14.12%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 14.02%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 14.02%


